September 2006 Back to Newsflow Summary

 
 
AstronClinica   Beau Visage combines skin imaging and consultation
 
IDTechEx   Lessons from RFID Acquisitions and Fund Raising
 
 
AstronClinica: Beau Visage combines skin imaging and consultation to help aesthetic medicine practitioners and their clients choose and track treatments over time. 7 September 2006
 

Beau Visage, the revolutionary new skin imaging and consultation product from Astron Clinica, enables aesthetic medicine practitioners to help their clients select appropriate treatments and track treatment progress over time in an independent, objective way. Beau Visage uses SIAscopy, Astron Clinica's unique patented skin imaging technology which gives practitioners and clients alike the opportunity to 'see' what is happening up to 2 mm beneath the surface of the skin and understand why their skin looks the way it does.

"Aesthetic medicine practitioners have three main problems," says Annie Brooking, CEO, Astron Clinica. "They need to make sure their clients understand the complexities of the skin, they need to ensure that their clients are fully informed in their choice of treatment and how it will affect their appearance, and they need to be able to demonstrate how a treatment is progressing, even when early results are not visible to the naked eye."

A Beau Visage consultation starts with an education session to help clients understand the structure of their skin, its chromophores: blood and melanin and how chromophores contribute to their appearance and skin tone. For the first time clients see separate facial maps of both their blood and melanin, zooming in on tiny details such as thread veins and skin damage.

In addition to visualising blood and melanin, Beau Visage has three in-built measurement systems, Sun Damage Scoring System, Skin Age assessment and Dr Leslie Baumann's Skin Typing Solution. All of these measurement systems help the client's treatment selection. Using Beau Visage, practitioners can identify a realistic and achievable skin goal working with the client, helping to manage expectations in a highly emotive area.

Beau Visage includes Beauty Timeline which is generated by images of blood, melanin and sun damage taken before every treatment session. These images are automatically compared as time goes on, and can show a percentage change in the skin before the customer can see change with the naked eye. "For years wrinkles have been considered the major indicator of age, it's not the case, an even skin tone is the primary indicator of youthful appearance" says Annie Brooking.

Beau Visage visualizes and measures skin tone and makes it easy to show clients what they could look like as a result of treatments that even out blood and melanin, the two chromophores that most affect the appearance of age. Recent scientific studies have shown that skin tone, colour and luminosity contribute directly to assessments of age.

Presented at the Human Behaviour and Evolution Society in June 2006, the study has shown that facial skin colour distribution, or tone, can add or subtract as much as 20 years to an assessment of age.*

Beau Visage also includes Dr Leslie Baumann's new Skin Type Solution, which helps the client choose the right products for their skin type.

Dr Baumann is one of the leading dermatologists in the USA, based at the University of Miami. Her book, The Skin Type Solution, has been a best seller in the USA. The skin typing programme that she has developed identifies 16 different types of skin and outlines the different skin care products appropriate to each skin type. "The very first time I heard about Beau Visage I wanted to be part of it. It truly offers a unique opportunity to aesthetic practitioners and their clients to see what is going on up to 2 mm under their skin and plan treatments and therapies based on individual need and skin type " Said Dr Baumann.

Beau Visage gives the rapidly burgeoning medi-spa movement worldwide a scientifically proven method of measurement and assessment to emphasise the effectiveness of various treatments in slowing down the appearance of skin aging.

Beau Visage was developed in conjunction with aesthetic medicine practitioners. Successful alpha tests at several medi-spas in the UK showed that the use of Beau Visage helped customers in their choices of treatment.

'Overtime, I fully expect Beau Visage consultations to lead to increased customer spend and loyalty. We have regular customers who will spend £5,000 or more every year on managing their appearance. Beau Visage enables the medi-spa practitioner to give the customer a unique confidence in the benefits of the treatment that they have selected, and because of the temporal range of the Beauty Timeline, supports customer loyalty directly.' Comments Tracy Bengougam, CEO, Pure Well Being medi-spa. 'Each consultation costs approximately £100, we have found that clients are very enthusiastic about the consultation process and the way it makes them feel empowered by their treatment and product choices.'

Beau Visage includes a tri-angle chin rig with camera mount, a specially calibrated digital camera and dedicated software, SIAscope IV, which runs on a PC. Medi-Spas can customise Beau Visage with their name and logo, product range and treatments.

Beau Visage is initially offered on a lease-to-own contract for £99 per week, including software, hardware, training and maintenance. Further information is available from Astron Clinica. The product is supported worldwide and is available in Spanish, French, German and Italian as well as English immediately.

*The study referred to earlier was written by Dr Karl Grammar and Dr Bernard Fink, scientists at the Ludwig-Boltzmann-Institute for Urban Ethnology (Austria) and the Department for Socio-biology/Anthropology at the University of Goettingen (Germany). The study, which was conducted in 2005 - 2006 and funded by Proctor & Gamble, used 3 -D imaging and morphing software technologies to remove wrinkles and bone structure from the equation to determine the true impact of facial skin colour distribution on the perception of a woman's age, health and attractiveness.

For more information please visit http://www.astronclinica.com

IDTechEx: Lessons from RFID Acquisitions and Fund Raising. 11 September 2006
 

In RFID, the amount of acquisition activity is picking up fast but is still well below what the market demands. With about 1000 companies doing something significant in the RFID value chain and mergers being less than the rate of formation of new RFID companies, there is scope for much more M&A activity and for the weak to disappear.

So far, the main reasons for RFID acquisitions are

  • Outsiders leveraging their non-RFID capability
  • Those early in the RFID value chain pulling through their product by buying more prosperous "late in the chain" system integrators etc
  • In filling gaps in capability
  • Creating critical mass often in a "key vertical" application

41% of the 34 RFID-related acquisitions that we have examined involve companies purchased in the US - far more than any other country. However, interestingly, there are more acquisitions made by companies from outside the US than in the US so far, the opposite of the situation with fund raising. The number of acquirors of RFID companies is increasing and their motives are increasingly varied. Many are entering the RFID business for the first time through acquisition.

In RFID, the amount of acquisition activity is picking up fast but is still well below what the market demands. With about 1000 companies doing something significant in the RFID value chain and mergers being less than the rate of formation of new RFID companies, there is scope for much more M&A activity and for the weak to disappear.

Systems suppliers and system integrators are increasingly favoured because they are landing the bigger orders and are more likely to be profitable because they suffer less competition. For example, system integrator Xterprise even claims to be profitable in the sector with the largest and most prevalent losses for suppliers - tagging pallets and cases for consumer goods companies. However, it would be dangerous to assume that this bias will last forever.

Earlier acquisitions have shown some bias to companies making tags or parts of tags but that is less evident recently. The tag makers that were purchased earlier have been subsumed into "soup to nuts" system supply in the main. By contrast, there is now a strong trend towards active RFID. IDTechEx market research shows that 20% of the money spent on RFID in 2006 involves active RFID but 24% of the fund raising and acquisition that we have examined involves active RFID. This is rational given that 26% of the money spent on RFID in 2016 will be on active RFID according to research by IDTechEx.

That is a trend that is also evident in the evolution of the IDTechEx RFID Knowledgebase of nearly 2100 case studies of RFID in 81 countries, about 60 new studies being added every month. Active RFID is of particular interest in the form of Real Time Locating Systems RTLS.

Read RFID Profit, Fund Raising and Acquisition Strategy, Active RFID 2006-2016 and Real Time Locating Systems 2006-2016.

For more information please visit http://www.idtechex.com

 
 

copyright © 2006 Added Value Capital Partners